Furthermore, mutant forms of the metabolic enzymes IDH1/2 have been identified as molecular drivers of a subset of gliomas previously known as IDH-mutant GBM, now classified as “Astrocytoma, IDH-mutant”4. The gene discussed is IDH1; the disease is central nervous system cancer.